key: cord-1026567-dpznmi8s
authors: Khan, Taimoor; Suleman, Muhammad; Ali, Syed Shujait; Sarwar, Muhammad Farhan; Ali, Imtiaz; Ali, Liaqat; Khan, Abbas; Rokhan, Bakht; Wang, Yanjing; Zhao, Ruili; Wei, Dong-Qing
title: Subtractive proteomics assisted therapeutic targets mining and designing ensemble vaccine against Candida auris for immune response induction
date: 2022-04-01
journal: Comput Biol Med
DOI: 10.1016/j.compbiomed.2022.105462
sha: 241a1002a58b6fddb1d6273747f696e951020013
doc_id: 1026567
cord_uid: dpznmi8s

The emergence of variants and the reports of co-infection caused by Candida auris in COVID-19 patients adds a further complication to the global pandemic situation. To date, no effective therapy is available for C. auris infections. Thus, characterization of therapeutic targets and designing effective vaccine candidates using subtractive proteomics and immune-informatics approaches is useful tool in controlling the emerging infections associated with SARS-CoV-2. In the current study, subtractive proteomics-assisted annotation of the vaccine targets was performed, which revealed seven vaccine targets. An immunoinformatic-driven approach was then employed to map protein-specific and proteome-wide immunogenic peptides (CTL, B cell, and HTL) for the design of multi-epitope vaccine candidates (MEVCs). The results demonstrated that the vaccine candidates possess strong antigenic features (>0.4 threshold score) and are classified as non-allergenic. Validation of the designed MEVCs through molecular docking, in-silico cloning, and immune simulation further demonstrated the efficacy of the vaccines by producing immune factor titers (ranging from 2500-16000 au/mL) i.e., IgM, IgG, IL-6, and Interferon-α. In conclusion, the current study provides a strong impetus in designing anti-fungal strategies against Candida auris.

Candida auris infections, and outbreaks caused by diverse fungal groups, pose a significant threat 60 to human health, and have affected almost 1.7 billion people worldwide. These infections are 61 associated with the immune invasion properties of these pathogens, causing skin and mucosa 62 diseases [1, 2] . Candida species are the major source of nosocomial infections, and 0.4 million 63 people are infected by it annually, with more than 40% of patients succumbing to it [1, 2] . Candida 64 auris was first isolated in 2009 from a female patient's ear discharge in Japan. This species is report the extremely high-quality matches [30] . The methodological workflow adopted in this 121 study is shown in Figure 1 . 

Prioritization of the essential proteins 126 The DEG (database of essential genes) (http://tubic.tju.edu.cn/deg/) contains information on key 127 proteins and genes that pathogens need to survive. These essential proteins are promising 128 candidates for vaccine development. Therefore, the important protein of Candida auris was found 129 by using the DEG online tools [31] . However, the CELLO online server determines the affinity score of each peptide. Binding affinity is strong for peptides with an IC50 148 value less than 50 nM. Peptides with an IC50 of less than 500 nM are intermediates, whereas 149 peptides with an IC50 of fewer than 5000 nM indicate poor epitope binding affinity. The peptides' 150 affinity scores and percentile rankings are inversely linked, which indicates that the higher the 151 binding affinity, the lower the percentile rank, and vice versa. The Algpred server 152 (http://www.imtech.res.in/raghava/algpred2/) [39, 40] with the TLR2 (Human Toll-like receptor-2). The server employs a hybrid docking method and 194 requires an amino acid sequence as input for analysis, setting it apart from other similar servers.

The HawkDock server provides experimental information on the protein-protein binding site and 196 small-angle x-ray drip quickly and authentically [46] . The putative vaccine design was modeled 197 using Robetta before protein-protein docking and the TLR-2 structure was acquired from the 198 ALPHAFOLD-2 using ID: AF-O60603-F1 [47] . The structure was prepared before the docking by 199 removing water molecules, heteroatom, and other atoms. ImmSim is a dynamic agent-based simulator for assessing the immunological responses of the 205 body to antigens. C-ImmSim uses an agent-based approach and the specific scoring matrix PSSM 206 to predict immune interactions and epitopes. Following the submission of the designed vaccine to 207 the online server with the default simulation settings, the production of antibodies, interferon, and 208 cytokines were measured; however, the same server was also used to check the reactions of both 209 Th1 and Th2 [49] .

In-silico cloning and codon optimization 212 We used the Java codon adaptation tool (JCat tool) for codon optimization and reversed translation 213 to produce the multi-epitope subunit vaccine in an appropriate vector [50] . The Jcat program is 214 also used to guarantee that the vaccination sequence is expressed at a high level in an appropriate pathogenesis. Next, we evaluated the antigenic and allergenic properties of these shortlisted 244 targets, which showed that only 7 proteins were determined as highly antigenic and non-allergenic, 245 shown in Table 1 . These target proteins include a mitochondrial import receptor subunit, two 246 putative beta-glucanase/Beta-glucan synthetases, two 1,3-beta-glucanosyltransferases, a uricase, 247 and a putative SUN family protein. with an antigenicity score of 0.7738, is also essential for regulating mitochondrial and cell wall 257 functions. All seven target proteins sequences retrieved from Uniprot [54] were then subjected to 258 epitope screening to find CTL, HTL, and B Cell epitopes. 

These epitopes were further analyzed by subjecting them to antigenicity and allergenicity checks.

The epitopes with high antigenic potential and non-allergenic status then proceeded to the next 285 step of vaccine design. During the CTL epitope prediction for protein A0A2H0ZE1, epitopes were shortlisted. All T-Cell epitopes selected for each protein were also screened for allergenicity 294 status before inclusion in the candidate vaccine designs, as shown in Table 2 . For protein A0A2H0ZE14, specific B cell epitopes were also predicted and two of these epitopes, Table 3 . Table 5 . This also included MEVC design based on the whole proteome, 328 including epitopes from all the seven target proteins. These linkers are vital to enabling epitope display, maintaining epitope separation, and protein-specific and proteome-wide putative vaccines are given in Table 6 . The widely used Robetta server generates highly efficacious structural models through parsing of 

Interaction of MEVCs with the Immune Receptor (TLR-2) 408 The HAWKDOCK server was employed to evaluate vaccine-TLR-2 interaction. The top ten 409 docking models of vaccine-TLR-2 were generated by the server, ranked based on docking complex 410 score. The docking scores acquired for each of the docking complexes are given in 

Represents the immune simulation graph for the vaccine designed against the whole proteome named as MEVC-WP.

Limitations of the study 506 This study was based on in silico analysis to shortlist putative epitopes which need validation in 

Hidden killers: human fungal infections

Candida auris: Epidemiology, biology, antifungal 541 resistance, and virulence

First hospital outbreak of the globally emerging Candida auris in a European hospital

Multiple introductions and subsequent transmission of multidrug-resistant Candida 547 auris in the USA: a molecular epidemiological survey, The Lancet Infectious diseases

Isolates of the emerging pathogen Candida auris present in 549 the UK have several geographic origins

Global epidemiology of emerging Candida auris, Current opinion in 551 microbiology

In vitro efficacy of disinfectants utilised for 553 skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris

Survival, persistence, 556 and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care 557 surface

Candida auris: epidemiological situation, 559 laboratory capacity and preparedness in the European Union and European Economic Area*

First three reported cases of 562 nosocomial fungemia caused by Candida auris

Multidrug-resistant Candida auris:'new kid on the block'in hospital-564 associated infections?

New clonal strain of Candida auris

Emerging infectious diseases

Candida auris-associated candidemia, South 569 Africa, Emerging infectious diseases

Candida auris candidemia 571 in Kuwait

First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia

Simultaneous emergence of multidrug-resistant Candida auris on 3 577 continents confirmed by whole-genome sequencing and epidemiological analyses

Candida auris candidaemia in Indian ICUs: analysis of risk factors

The lurking scourge of multidrug resistant Candida auris in times of COVID-583 19 pandemic

Rationally 585 Designed Small-Molecule Inhibitors Targeting an Unconventional Pocket on the TLR8 Protein-Protein

Characteristics of and important lessons from the coronavirus disease 2019 588 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease 589 Control and Prevention

Secondary bacterial infections 591 in patients with viral pneumonia

Could the COVID-19 pandemic aggravate antimicrobial 593 resistance?

Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related 596 emerging species

Draft genome of a 598 commonly misdiagnosed multidrug resistant pathogen Candida auris

Evaluation of the Whole Proteome of Achromobacter xylosoxidans to Identify Vaccine Targets for 601 mRNA and Peptides-Based Vaccine Designing Against the Emerging, leukemia (AML)

Genome-wide screening of vaccine targets prioritization and reverse vaccinology aided design of peptides 604 vaccine to enforce humoral immune response against Campylobacter jejuni

UniProt: the universal protein knowledgebase

Subtractive proteomics and immunoinformatics approaches to explore Bartonella bacilliformis proteome 609 (virulence factors) to design B and T cell multi-epitope subunit vaccine, Infection

Proteome-wide mapping and reverse vaccinology-based B and T cell multi-epitope subunit 613 vaccine designing for immune response reinforcement against Porphyromonas gingivalis

Subtractive proteomics to identify novel drug targets and reverse vaccinology 616 for the development of chimeric vaccine against Acinetobacter baumannii

DEG: a database of essential genes

Prediction of protein subcellular localization, Proteins: 621 Structure, Function, and Bioinformatics

A web resource for designing subunit vaccine against major 623 pathogenic species of bacteria

VaxiJen: a server for prediction of protective antigens, tumour antigens 625 and subunit vaccines

Protein identification and 627 analysis tools on the ExPASy server, The proteomics protocols handbook

NetCTLpan: pan-specific MHC class I pathway 629 epitope predictions

CytomegaloVirusDb: multi-Omics knowledge 631 database for Cytomegaloviruses

MMV-db: vaccinomics and RNA-based therapeutics database for 633 infectious hemorrhagic fever-causing mammarenaviruses

Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine 636 against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation, 637 Computers in biology and medicine

AlgPred 2.0: an improved method 639 for predicting allergenic proteins and mapping of IgE epitopes

Prediction of continuous B-cell epitopes in an antigen using recurrent neural 642 network

ElliPro: a new structure-644 based tool for the prediction of antibody epitopes

Designing of interferon-gamma inducing MHC class-II binders

Design of the linkers which effectively 648 separate domains of a bifunctional fusion protein

Protein structure prediction and analysis using the Robetta server, 650 Nucleic acids research

HawkDock: a web server to predict and analyze 652 the protein-protein complex based on computational docking and MM/GBSA

Highly accurate protein structure prediction with AlphaFold

C-immsim: playing with the immune response

Verification of protein structures: patterns of nonbonded atomic interactions, 659 Protein science

JCat: a novel tool to 661 adapt codon usage of a target gene to its potential expression host

Exploring Leishmania secretory proteins to design B and T 664 cell multi-epitope subunit vaccine using immunoinformatics approach

Towards an Ensemble Vaccine against the Pegivirus Using Computational Modelling Approaches 667 and Its Validation through In Silico Cloning and Immune Simulation, Vaccines

BC-TFdb: a database of transcription factor drivers in breast cancer

UniProt: a hub for protein information

Defensins act as potent adjuvants that promote cellular and humoral immune 673 responses in mice to a lymphoma idiotype and carrier antigens

Human beta-676 defensin 3 induces maturation of human Langerhans cell-like dendritic cells: an antimicrobial peptide that 677 functions as an endogenous adjuvant